We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 75 results
  1. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass

    Summary

    Osteoporosis-pseudoglioma syndrome (OPPG) and LRP5 high bone mass (LRP5-HBM) are two rare bone diseases with opposite clinical symptoms caused...

    Na Ren, Shanshan Lv, ... Chun Wang in Osteoporosis International
    Article Open access 16 April 2024
  2. Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients’ management using bisphosphonates therapy

    Summary

    This study describes the clinical, radiological, and molecular data of four new patients with osteoporosis-pseudoglioma syndrome and assesses...

    Mohamed S. Abdel-Hamid, Rasha M. Elhossini, ... Mona S. Aglan in Osteoporosis International
    Article 01 February 2022
  3. Family analysis and literature study of hereditary hypophosphatemic rickets with hypercalciuria

    Background

    Hereditary hypophosphatemia rickets with hypercalciuria (HHRH) is a rare autosomal recessive disorder characterised by reduced renal...

    Lufeng Wang, Gulimire Kulaixi, ... Yanying Guo in BMC Pediatrics
    Article Open access 14 February 2024
  4. A familial missense variant in the Alzheimer’s disease gene SORL1 impairs its maturation and endosomal sorting

    The SORL1 gene has recently emerged as a strong Alzheimer’s Disease (AD) risk gene. Over 500 different variants have been identified in the gene and...

    Elnaz Fazeli, Daniel D. Child, ... Jessica E. Young in Acta Neuropathologica
    Article Open access 20 January 2024
  5. Pamidronic-acid

    Article 18 March 2023
  6. Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients

    Osteoporosis may affect young individuals, albeit infrequently. In childhood, bone mass increases, reaching its peak between the second and third...

    Stefania Costi, Teresa Giani, ... Rolando Cimaz in Pediatric Drugs
    Article 11 January 2022
  7. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece

    Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal-recessive disorder, characterized by severe osteoporosis and early-onset blindness....

    Iordanis Papadopoulos, Evangelia Bountouvi, ... Anna Papadopoulou in European Journal of Pediatrics
    Article 29 November 2018
  8. Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG)

    Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal recessive syndrome characterized by juvenile-onset osteoporosis and ocular...

    M. Celli, P. D’Eufemia, ... A. Zambrano in Osteoporosis International
    Article 02 September 2017
  9. Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease

    Wnts are secreted, lipid-modified proteins that bind to different receptors on the cell surface to activate canonical or non-canonical Wnt signaling...

    Lifang Hu, Wei Chen, ... Yi-** Li in Bone Research
    Article Open access 10 July 2024
  10. The Genetics of Atypical Femur Fractures—a Systematic Review

    Purpose of Review

    Atypical femur fractures (AFFs) are rare subtrochanteric or diaphyseal fractures regarded as side effects of bisphosphonates (BPs),...

    Wei Zhou, Jeroen G. J. van Rooij, ... M. Carola Zillikens in Current Osteoporosis Reports
    Article Open access 15 February 2021
  11. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders

    Summary

    Wnt signaling and its bone tissue–specific inhibitor sclerostin are key regulators of bone homeostasis. The therapeutic potential of...

    Francesca Marini, Francesca Giusti, ... Maria Luisa Brandi in Osteoporosis International
    Article 18 August 2022
  12. The evolving therapeutic landscape of genetic skeletal disorders

    Background

    Rare bone diseases account for 5% of all birth defects yet very few have personalised treatments. Developments in genetic diagnosis,...

    Ataf Hussain Sabir, Trevor Cole in Orphanet Journal of Rare Diseases
    Article Open access 30 December 2019
  13. Intraoperative conversion from laparoscopic gastrectomy to an open procedure: a decade of experience in a Japanese high-volume center

    Background

    Although laparoscopic gastrectomy (LG) is a widely accepted treatment for gastric cancer, conversion to laparotomy is sometimes required....

    Koshi Kumagai, Naoki Hiki, ... Takeshi Sano in Surgical Endoscopy
    Article 30 April 2020
  14. Looking at Mountains: Role of Sustained Hypoxia in Regulating Bone Mineral Homeostasis in Relation to Wnt Pathway and Estrogen

    Deteriorated bone microarchitecture is a major health concern affecting millions worldwide, amounting to high mortality along with psychological,...

    Lijy K. Babu, Dishari Ghosh in Clinical Reviews in Bone and Mineral Metabolism
    Article 22 November 2022
  15. Sclerostin: from bench to bedside

    Skeletal integrity is maintained by a meticulous balance between bone resorption and bone formation, and recent studies have revealed the essential...

    Sakae Tanaka, Toshio Matsumoto in Journal of Bone and Mineral Metabolism
    Article 18 November 2020
  16. Inducible expression of Wnt7b promotes bone formation in aged mice and enhances fracture healing

    There remain unmet clinical needs for safe and effective bone anabolic therapies to treat aging-related osteoporosis and to improve fracture healing...

    Deye Song, Guangxu He, ... Fanxin Long in Bone Research
    Article Open access 03 February 2020
  17. Anabolic Therapy for the Treatment of Osteoporosis in Childhood

    Purpose of Review

    Numerous forms of osteoporosis in childhood are characterized by low bone turnover (for example, osteoporosis due to neuromuscular...

    Leanne M. Ward, Frank Rauch in Current Osteoporosis Reports
    Article 27 March 2018
  18. Role of thyroid hormones in craniofacial development

    The development of the craniofacial skeleton relies on complex temporospatial organization of diverse cell types by key signalling molecules. Even...

    Victoria D. Leitch, J. H. Duncan Bassett, Graham R. Williams in Nature Reviews Endocrinology
    Article 23 January 2020
  19. Hypoxia Signaling in the Skeleton: Implications for Bone Health

    Purpose of Review

    We reviewed recent literature on oxygen sensing in osteogenic cells and its contribution to development of a skeletal phenotype, the...

    Clare E. Yellowley, Damian C. Genetos in Current Osteoporosis Reports
    Article 06 February 2019
  20. Exploiting the WNT Signaling Pathway for Clinical Purposes

    Purpose of Review

    The goal of this paper is to evaluate critically the literature published over the past 3 years regarding the Wnt signaling pathway....

    Mark L. Johnson, Robert R. Recker in Current Osteoporosis Reports
    Article 21 April 2017
Did you find what you were looking for? Share feedback.